Communiqués Maravai LifeSciences Holdings, Inc.

Actions

MRVI

US56600D1072

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 31/05/2024			Varia. 5j.	Varia. 1 janv.
8,67 ^USD	-2,47 %		-20,09 %	+32,37 %

15/05	Transcript : Maravai LifeSciences Holdings, Inc. Presents at 2024 RBC Capital Markets Global Healthcare Conference, May-15-2024 03:35 PM
09/05	MARAVAI LIFESCIENCES HOLDINGS, INC. : UBS n'est pas inspiré par le dossier	ZM

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

TriLink BioTechnologies collaborates with Johns Hopkins University to establish a new RNA Innovation Center	13/05	BU
Maravai LifeSciences Announces May and June 2024 Investor Conference Schedule	09/05	GL
Maravai LifeSciences : Conflict Minerals Statement	08/05	PU
Maravai LifeSciences : Q1 2024 Earnings	08/05	PU
Maravai LifeSciences Reports First Quarter 2024 Financial Results	08/05	GL
TriLink BioTechnologies and Lonza Enter into Non-exclusive License and Supply Agreement for CleanCap mRNA Capping Technology	01/05	AQ
TriLink BioTechnologies® et Lonza signent un contrat de licence et d'approvisionnement non exclusif pour la technologie de capsulage d'ARNm CleanCap®	30/04	BU
TriLink BioTechnologies® and Lonza Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology	30/04	BU
TriLink BioTechnologies Announces New San Diego Facility for Late Phase mRNA Drug Substance Production	19/04	AQ
TriLink BioTechnologies® annonce un nouveau site à San Diego pour la production de substances médicamenteuses à base d'ARNm au stade ultime de leur développement	18/04	BU
TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production	18/04	BU
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, May 8, 2024	10/04	GL
Dyadic International Inc. (NASDAQ: DYAI) Funding to Propel Near-Term Revenue Growth Initiatives Highlights in Zacks Small-Cap Research Report	04/04	AQ
Maravai LifeSciences Announces March 2024 Investor Conference Schedule	12/03	GL
Recent Market Movers: Healthcare Companies Making Headlines: DYAI, RIGL, ARDX, VERO, MEDS	28/02	AQ
Healthcare Undervalued Opportunities Poised for Growth: DYAI, INBS, VTAK, RSCI, VERO, MRVI	27/02	AQ
Maravai LifeSciences Reports Fourth Quarter and Full Year 2023 Financial Results	22/02	GL
TriLink BioTechnologies Solidifies IP Position with Awarded Patents for CleanCap Capping Technology in China and Canada	22/02	AQ
TriLink BioTechnologies® Solidifies IP Position with Awarded Patents for CleanCap® Capping Technology in China and Canada	21/02	BU
Nasdaq Stocks Are Taking Center Stage This Week! DYAI, MRVI, SPWR, VTAK, KAVL, INBS	19/02	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Maravai LifeSciences Holdings, Inc.

Actions

MRVI

US56600D1072

Communiqués

Filtres